Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 7.89
-0.01 (-0.13%)
Sep 4, 2026, 3:00 PM CST
SHA:603707 Market Cap
SHA:603707 has a market cap or net worth of 12.74 billion as of September 4, 2026. Its market cap has decreased by -31.57% in one year.
Market Cap
12.74B
Enterprise Value
11.55B
Revenue
3.94B
Ranking
n/a
PE Ratio
26.17
Stock Price
7.89
ChartMarket Cap Chart
Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 12.74B, an increase of 189.74%. That is a compound annual growth rate of 12.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.74B | -12.70% |
| Dec 31, 2025 | 14.59B | -31.95% |
| Dec 31, 2024 | 21.44B | -11.29% |
| Dec 29, 2023 | 24.17B | -16.87% |
| Dec 30, 2022 | 29.08B | -44.15% |
| Dec 31, 2021 | 52.06B | 59.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Kangtai Biological Products | 14.37B |
| Zhejiang Hisun Pharmaceutical | 13.66B |
| Zhejiang Jiuzhou Pharmaceutical | 13.26B |
| Shenzhen Hepalink Pharmaceutical Group | 13.14B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.12B |
| Zhejiang Medicine | 12.05B |
| Guobang Pharma | 11.88B |
| Wedge Industrial | 11.67B |